Ich hab mir zwei shows online angeschaut !
Calypte Biomedical and Earvin 'Magic' Johnson Commemorate World AIDS Day December 1st
ALAMEDA, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (BULLETIN BOARD: CYPT) , the developer and marketer of the only two FDA approved HIV-1 antibody tests for use with urine samples, today announced that Calypte's Chairman Tony Cataldo and "Magic" Ervin Johnson spent December 1st, World AIDS Day, speaking on the importance of HIV/AIDS testing.
"World AIDS Day is the ideal time for everyone to commit to being tested," said Johnson. "It's a day when we can take on the rampant spread of HIV one person at a time," he added. Calypte's Chairman Anthony Cataldo stated, "Early detection can significantly alter the quality of life, and can help prevent the spread of HIV and can ultimately save lives."
Magic Johnson first appeared on NBC's Today Show followed by an interview on BET and ABC radio. Both Mr. Cataldo and Mr. Johnson appeared on MSNBC and Fox News, Your World with Neal Cavuto to discuss the company and highlight the need for HIV/AIDS testing.
To access these events please go to the company's web site at www.calypte.com/ About The Magic Johnson Foundation
The Magic Johnson Foundation was established in 1991 as a single-disease organization that worked to raise funds for community-based organizations dealing with HIV/AIDS education and prevention programs. The Foundation has since responded to the growing need to address all aspects of our youth's lives by expanding its mission. This expanded mission emphasizes the Foundation's focus on supporting community-based organizations and developing programs that serve the health, educational and social needs of those residing in inner-city communities. In addition, the Foundation has made a strong commitment to raise awareness about many of the health and social concerns that threaten under-served communities.
About Calypte Biomedical
Calypte Biomedical Corporation, headquartered in Alameda, California, is a public healthcare company dedicated to the development and commercialization of urine-based diagnostic products and services for Human Immunodeficiency Virus Type 1 (HIV-1), sexually transmitted diseases and other infectious diseases. Calypte's tests include the screening EIA and supplemental Western Blot tests, the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA-approved serum HIV-1 antibody Western Blot test. The Company believes that accurate, non-invasive urine-based testing methods for HIV and other infectious diseases may make important contributions to public health by helping to foster an environment in which testing may be done safely, economically, and painlessly.